Skip to content

Effectiveness of bracing patients with adolescent idiopathic scoliosis.

Effectiveness of bracing patients with adolescent idiopathic scoliosis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23157
Enrollment
100
Registered
2006-01-17
Start date
2006-01-19
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis (AIS)

Interventions

Patients in the intervention group will be treated with a brace. The brace is a device that fits closely around the body to exert pressure to the trunk in order to push the spine into a straighter pos

Sponsors

Erasmus MC, dept. of Public Health P.O. Box 1738 3000 DR Rotterdam the Netherlands tel.: + 31 10 4087714 fax: + 31 10 4089449
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eligible patients are girls and boys in the age group 8-15 years whose diagnosis of AIS has been established by an orthopaedic surgeon, who have not yet been treated by bracing or surgery and for whom further growth of physical height is still expected based on medical examination and maturation characteristics (Risser sign) established by X-ray. To expect further growth of physical height, patients only with Risser sign < 3 will be included. As agreed in the consensus by de different health professionals in the orthopaedic field, the Cobb angle should either be minimally 22 and maximally 29 degrees with established progression of more than 5 degrees or should be minimally 30 and maximally 35 degrees; progression for the latter is not necessarily established.

Exclusion criteria

Exclusion criteria: Patients with other forms of scoliosis (e.g. as a result of neuromuscular diseases) are excluded.

Design outcomes

Primary

MeasureTime frame
Cobb angle, two years after inclusion.

Secondary

MeasureTime frame
Quality of life, patient preferences, costs.

Contacts

Public ContactE.M. Bunge

Erasmus Medical Center, Department of Public Health, P.O.Box 1738

e.bunge@erasmusmc.nl+31 (0)10 4087498

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)